DarioHealth Corp. (DRIO) |
| 7.15 0.17 (2.44%) 09-04 14:14 |
| Open: | 6.94 |
| High: | 7.15 |
| Low: | 6.79 |
| Volume: | 18,056 |
| Market Cap: | 52(M) |
| PE Ratio: | -1.22 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 8.20 |
| Resistance 1: | 7.43 |
| Pivot price: | 7.15 |
| Support 1: | 6.19 |
| Support 2: | 5.15 |
| 52w High: | 17.744 |
| 52w Low: | 5.845 |
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
| EPS | -14.870 |
| Book Value | 7.500 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.319 |
| Profit Margin (%) | -169.87 |
| Operating Margin (%) | -125.15 |
| Return on Assets (ttm) | -19.4 |
| Return on Equity (ttm) | -59.9 |
Thu, 20 Aug 2026
DarioHealth (DRIO) Upgraded to Buy: Here's Why - Eastern Progress
Mon, 17 Aug 2026
DarioHealth Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Fri, 14 Aug 2026
Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report - simplywall.st
Wed, 12 Aug 2026
DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands - Streetwise Reports
Tue, 11 Aug 2026
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates - finance.yahoo.com
Tue, 11 Aug 2026
DarioHealth Reports Second Quarter 2026 Financial Results - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |